Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, February 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#5 of 2,564)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 1 news outlet
twitter: 146 X users
patent: 6 patents

facebook: 10 Facebook pages
reddit: 1 Redditor

Citations

dimensions_citation: 236 Dimensions

Readers on

mendeley: 163 Mendeley

Summary News X Patents Facebook Reddit Dimensions citations

So far, Altmetric has seen 11 public wall posts from 10 users.

Angalee Jones, 04 Jan 2015

IV vitamin C doubles survival time of pancreatic cancer patients in new clinical trial Sunday, February 17, 2013 by: Ethan…

Living Health Therapies, 19 Feb 2013

Vitamin C and…

Centinela Animal Hospital, Inc., 19 Feb 2013

Our office has advocated using high dose intravenous vitamin C for many years. New research in humans supports this integrative…

Ahvma Foundation, 19 Feb 2013

Intravenous vitamin C has been shown to prolong human pancreatic cancer survival. Holistic veterinarians have long said that…

WildRaw, 19 Feb 2013

Vitamin C and…

Vaccines-Unavoidably Unsafe, 17 Feb 2013

Sun and Sutra.Com, 17 Feb 2013

Great Mothers (and others) Questioning Vaccines, 17 Feb 2013

The C.A.S.H Card Project, 17 Feb 2013

IV vitamin C doubles survival time of pancreatic cancer patients in new clinical…

Lindsay Bunn Rogers, 17 Feb 2013

IV vitamin C doubles survival time of pancreatic cancer patients in new clinical…

Citizens Action Network, 17 Feb 2013

IV vitamin C doubles survival time of pancreatic cancer patients in new clinical trial Sunday, February 17, 2013 by: Ethan…